Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is D1000 Varejo Farma Participacoes EV-to-EBIT?
D1000 Varejo Farma ParticipacoesBSP:DMVF3 +0.16%80 EV-to-EBIT is 8.84 as of Jul. 24, 2026, which is 20% below its 10-year median of 11.03. GuruFocus rates BSP:DMVF3 with a GF Score™ of 80/100 and a GF Value™ of R$8.14 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 469 Healthcare Providers & Services companies, D1000 Varejo Farma Participacoes ranks better than 78.46% on this metric.
The historical rank and industry rank for D1000 Varejo Farma Participacoes's EV-to-EBIT or its related term are showing as below:
BSP:DMVF3'
s EV-to-EBIT Range Over the Past 10 Years
Min: 7.86 Med: 11.03 Max: 105.3
Current: 8.84
During the past 9 years, the highest EV-to-EBIT of D1000 Varejo Farma Participacoes was 105.30. The lowest was 7.86. And the median was 11.03.
BSP:DMVF3's EV-to-EBIT is ranked better than 78.46% of 469
companies
in the Healthcare Providers & Services industry
Industry Median: 15.87
vs BSP:DMVF3: 8.84
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
D1000 Varejo Farma Participacoes's Enterprise Value for the quarter that ended in Mar. 2026 was R$873 Mil.
D1000 Varejo Farma Participacoes's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
D1000 Varejo Farma Participacoes EV-to-EBIT Related Terms
D1000 Varejo Farma Participacoes EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, D1000 Varejo Farma Participacoes's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
D1000 Varejo Farma Participacoes EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, D1000 Varejo Farma Participacoes's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where D1000 Varejo Farma Participacoes's EV-to-EBIT falls into.
D1000 Varejo Farma Participacoes's current Enterprise Value is R$834 Mil.
D1000 Varejo Farma Participacoes's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
D1000 Varejo Farma Participacoes (BSP:DMVF3) has a EV-to-EBIT of 8.84 as of Jul. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on D1000 Varejo Farma Participacoes and its competitors. This is 20% below median its historical median of 11.03. Over the past decade, D1000 Varejo Farma Participacoes' EV-to-EBIT has ranged from 7.86 to 105.30. According to the industry distribution chart, D1000 Varejo Farma Participacoes ranks #101 out of 469 companies in the Healthcare Providers & Services industry, placing it in the top 21.5%.
Is D1000 Varejo Farma Participacoes' EV-to-EBIT too high?
D1000 Varejo Farma Participacoes' current EV-to-EBIT of 8.84 is 20% below median its 10-year median of 11.03. Over the past 10 years, this metric has ranged from a low of 7.86 to a high of 105.30. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. D1000 Varejo Farma Participacoes' value of 8.84 is 44.3% below this industry median. Based on the distribution chart, D1000 Varejo Farma Participacoes ranks #101 out of 469 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, D1000 Varejo Farma Participacoes has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does D1000 Varejo Farma Participacoes' EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, D1000 Varejo Farma Participacoes ranks #101 out of 469 companies for EV-to-EBIT. This places D1000 Varejo Farma Participacoes in the top 22% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.87. D1000 Varejo Farma Participacoes' value of 8.84 is 44.3% below this benchmark. Historically, D1000 Varejo Farma Participacoes' own EV-to-EBIT has ranged from 7.86 to 105.30 over the past decade. While the company's 10-year median is 11.03 vs. the industry median of 15.87, D1000 Varejo Farma Participacoes has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. D1000 Varejo Farma Participacoes's current EV-to-EBIT of 8.84 is 44.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on D1000 Varejo Farma Participacoes and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. D1000 Varejo Farma Participacoes's current EV-to-EBIT is 8.84, which is 20% below median its own 10-year median of 11.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D1000 Varejo Farma Participacoes stock overvalued right now?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes (BSP:DMVF3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.14, compared to a current price of R$6.36 — trading 21.9% below its estimated fair value. The current EV-to-EBIT is 8.84, which is 20% below median its 10-year median of 11.03 and 44.3% below the Healthcare Providers & Services industry median of 15.87. D1000 Varejo Farma Participacoes' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For D1000 Varejo Farma Participacoes (BSP:DMVF3), the current EV-to-EBIT is 8.84 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is D1000 Varejo Farma Participacoes (BSP:DMVF3) Overvalued in 2026?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes stock appears to be undervalued.
The current stock price of R$6.36 is trading 21.9% below its estimated GF Value™ of R$8.14.
GuruFocus considers D1000 Varejo Farma Participacoes to be Modestly Undervalued.
Key valuation signals for BSP:DMVF3:
EV-to-EBIT: 8.84 (20% below median its 10-year median of 11.03)
GF Value™: R$8.14 vs. price of R$6.36 (21.9% below fair value)
Industry Position: 44.3% below the Healthcare Providers & Services median (#101 of 469)
No single metric tells the full story. See the BSP:DMVF3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
D1000 Varejo Farma Participacoes Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:DMVF3 has been successfully added to your 
